This concurs with a recent report by Ohigashi et al, who showed that inhibition of Wnt signaling by the Wnt inhibitory factor-1 down-regulated the AKT pathway, leading to enhanced chemosensitivity in PTEN-null prostate cancer cells [43]. Here, AKT1 is linked to prostate carcinoma.